CN Stock MarketDetailed Quotes

Luyan Pharma (002788)

Watchlist
  • 19.68
  • -2.19-10.01%
Market Closed Jan 16 15:00 CST
7.65BMarket Cap24.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Luyan Pharma (002788) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Drugs8.65B83.20%
medical apparatus1.2B11.54%
Traditional Chinese medicine slice438.53M4.22%
Other108.73M1.05%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Medicine wholesale9.4B90.43%
Pharmaceutical retail688.5M6.62%
Pharmaceutical industry278.99M2.68%
Other business27.96M0.27%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Fujian Province7.28B69.96%
Sichuan Province1.8B17.32%
Jiangxi province992.45M9.54%
Other provinces and cities330.2M3.17%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -